What is the UMB Institute for Clinical & Translational Research (ICTR)?
The UMB ICTR is a clinical translational research initiative supported by the UMB campus.
The UMB ICTR is a campuswide clinical translational research initiative supported by the UMB campus. The UMB ICTR provides financial support as well as infrastructure, environment, training, and workforce to invigorate, facilitate, and accelerate clinical translational research to improve patient and community health. This site will highlight ICTR-supported resources as well as other campuswide shared resources and community-engagement activities. If you are unsure of the "next steps" or have problems with the ICTR website, please email ICTR Research Navigator and visit this site often for new and expanding UMB ICTR resources. To learn more about UMB ICTR and the tremendous support from the UMB campus, visit About UMB ICTR.
SUBSCRIBE TO THE ICTR EMAIL LIST for the latest announcements about ICTR funding opportunities, Enrichment Seminar Series presentations and more.
September 28, 2021 | For the latest on funding and training grant opportunities and other UMB ICTR/CTSA events, follow us on Twitter @UMBICTR
September 28, 2021 | The UMB HSHSL can help UMB faculty with accessing this data. Email JP Courneya firstname.lastname@example.org or Amy Yarnell email@example.com
May 26, 2021 | UMB ICTR TL1 Scholars Program Director, Dr.Luana Colloca, co-chairs the planning committee for SIPS, an international association of scholars who share the goal of understanding the placebo effect in medical treatment, psychotherapy, and complementary and alternative treatment. Expert faculty from the UMB Schools of Medicine, Nursing and Pharmacy collaborated with SIPS to design an intehttps://sirdisciplinary, international scientific conference to advance the science of placebo research and ...
November 09, 2020 | While the nation is undergoing unprecedent pandemic and opioid crises, Internal KL2 Scholars from UMB’s Institute of Clinical Translational Research (ICTR) are thriving and meeting these healthcare challenges. Read more...